Jackson Square Partners Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
LPL Financial
LPLA
|
+$129M |
| 2 |
Charles River Laboratories
CRL
|
+$106M |
| 3 |
AZPN
Aspen Technology Inc
AZPN
|
+$105M |
| 4 |
Warner Music
WMG
|
+$105M |
| 5 |
Papa John's
PZZA
|
+$45.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$379M |
| 2 |
Mastercard
MA
|
+$235M |
| 3 |
Grocery Outlet
GO
|
+$203M |
| 4 |
Visa
V
|
+$197M |
| 5 |
Tandem Diabetes Care
TNDM
|
+$174M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.71% |
| 2 | Technology | 21.01% |
| 3 | Communication Services | 15.24% |
| 4 | Industrials | 14.99% |
| 5 | Financials | 11.06% |
Similar funds
Jackson Square Partners's Q2 2022 Portfolio in Review
As of Q2 2022, Jackson Square Partners held 104 positions worth $4.28B, down 57% from $10.1B the previous quarter. Its ten largest holdings account for 44% of the portfolio.
Jackson Square Partners withdrew a net $3.71B in Q2 2022, closing 14 positions and reducing 58 holdings. Its most notable exit was Tandem Diabetes Care, an estimated $174M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 24% of assets, up from 20% a quarter earlier, followed by Technology and Communication Services.
Against the trend, Jackson Square Partners opened a new position in LPL Financial worth $125M.
- Jackson Square Partners's largest Q2 2022 buy was LPL Financial: 677,978 shares worth $125M.
- Jackson Square Partners added most to Charles River Laboratories in Q2 2022, an estimated $106M increase.
- Jackson Square Partners's biggest Q2 2022 reduction was Microsoft, cutting an estimated $379M.
- Jackson Square Partners fully exited Tandem Diabetes Care in Q2 2022, selling an estimated $174M.
- Jackson Square Partners's ten largest holdings make up 44% of its $4.28B portfolio in Q2 2022.
- Jackson Square Partners opened 9 new positions and closed 14 in Q2 2022.
- Jackson Square Partners's portfolio value fell 57% quarter-over-quarter to $4.28B.
Based on Jackson Square Partners's 13F filing for Q2 2022, filed 12 Aug 2022.